Coronary disease & ACSCohort study

Safety, Feasibility, and Diagnostic Yield of Invasive Coronary Function Testing

JAMA CardiolPublished

  • Quality improvement study using a prospective observational registry
  • multicentre (15 hospitals: 2 tertiary, 13 nontertiary)

Authors' conclusion

This study found that a CFT was feasible and safe to perform in both tertiary and nontertiary centers with a high diagnostic yield.

Study context

Population
Patients with angina and no obstructive CAD clinically referred for invasive coronary function testing (coronary function test (CFT)), Netherlands, December 2020–January 2024978 (81%) female
Participants
1,207 patients
Outcome
Prevalence of coronary vasomotor dysfunction endotypes and overall safety of CFT

Main finding

As reported in the abstract

Prevalence of coronary vasomotor dysfunction

Coronary vasomotor dysfunction

78%

Observational data: associations, not effects.

Safety

Complications of CFT

Major complications
11 (0.9%)
Minor complications
10 (0.8%)
Major complications definitely related to CFT
3
Procedural death, MI or stroke
0
No differences in complications between tertiary and nontertiary centres
  • all minor complications definitely related to CFT

Original publication

Safety, Feasibility, and Diagnostic Yield of Invasive Coronary Function Testing. JAMA Cardiol. Published 1 April 2025. doi:10.1001/jamacardio.2024.5670

Summarised from the published abstract; every number is checked against it